HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ron Hoffman Selected Research

Tacrolimus (Prograf)

6/2004Drug-related thrombosis in hematologic malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ron Hoffman Research Topics

Disease

4Hemorrhage
01/2009 - 01/2004
3Thrombosis (Thrombus)
10/2023 - 06/2004
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2019 - 10/2005
2Leukemia
11/2019 - 11/2005
2Infections
03/2019 - 09/2016
2Thrombocytopenia (Thrombopenia)
03/2019 - 10/2005
2Venous Thromboembolism
10/2018 - 06/2004
2Hematologic Neoplasms (Hematological Malignancy)
09/2016 - 10/2005
2Neoplasms (Cancer)
01/2016 - 12/2006
2Body Weight (Weight, Body)
10/2005 - 01/2004
2Activated Protein C Resistance (APC Resistance)
07/2002 - 02/2002
1Pregnancy Complications
10/2023
1Mental Disorders (Mental Disorder)
07/2022
1Syncope (Fainting)
03/2022
1Pulmonary Embolism
03/2022
1Hemophilia A (Haemophilia)
03/2019
1Breast Neoplasms (Breast Cancer)
01/2016
1Glioma (Gliomas)
01/2016
1Thromboembolism
09/2012
1Chronic Renal Insufficiency
10/2011
1Aplastic Anemia (Anemia, Hypoplastic)
10/2005
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2005
1Ischemic Stroke
10/2005
1T-Cell Lymphoma (Lymphoma, T Cell)
10/2005
1Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2005
1Burkitt Lymphoma (Burkitt's Lymphoma)
10/2005
1Hodgkin Disease (Hodgkin's Disease)
10/2005
1Acute Promyelocytic Leukemia
01/2005
1Thrombotic Microangiopathies
06/2004
1Central Nervous System Diseases (CNS Diseases)
01/2003
1Primary Myelofibrosis (Myelosclerosis)
03/2002
1Thrombophilia
02/2002
1Antithrombin III Deficiency
02/2002

Drug/Important Bio-Agent (IBA)

4AnticoagulantsIBA
10/2011 - 01/2004
3fibrin fragment D (D-dimer)IBA
03/2022 - 01/2004
3Protein CIBA
12/2006 - 02/2002
2Hemostatics (Antihemorrhagics)IBA
10/2018 - 01/2005
2factor V LeidenIBA
07/2002 - 02/2002
2Protein SIBA
07/2002 - 02/2002
1Enoxaparin (Lovenox)FDA LinkGeneric
10/2023
1Indicators and Reagents (Reagents)IBA
07/2022
1Cytarabine (Cytosar-U)FDA LinkGeneric
11/2019
1ProdrugsIBA
11/2019
1Rituximab (Mabthera)FDA Link
03/2019
1AntibodiesIBA
03/2019
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2019
1Heparin (Liquaemin)FDA LinkGeneric
03/2019
1Platelet Activating FactorIBA
03/2019
1SteroidsIBA
03/2019
1Erythropoietin Receptors (Erythropoietin Receptor)IBA
01/2016
1heparanaseIBA
01/2016
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
09/2012
1Warfarin (Coumadin)FDA LinkGeneric
09/2012
1Urokinase Plasminogen Activator ReceptorsIBA
11/2005
1ThrombomodulinIBA
11/2005
1lipoprotein-associated coagulation inhibitor (TFPI)IBA
11/2005
1Thromboplastin (Tissue Factor)IBA
11/2005
1PAR-1 ReceptorIBA
11/2005
1recombinant FVIIa (rFVIIa)FDA Link
10/2005
1Factor VIIa (Activated Factor VII)IBA
10/2005
1GemcitabineFDA Link
06/2004
1Bleomycin (Blenoxane)FDA LinkGeneric
06/2004
1Cisplatin (Platino)FDA LinkGeneric
06/2004
1Thalidomide (Thalomid)FDA Link
06/2004
1Tacrolimus (Prograf)FDA LinkGeneric
06/2004
1Cyclosporine (Ciclosporin)FDA LinkGeneric
06/2004
1prothrombin complex concentrates (PPSB)IBA
01/2004
1SolventsIBA
01/2004
1Detergents (Detergent)IBA
01/2004
1Prothrombin (Factor II)IBA
02/2002
1Antiphospholipid AntibodiesIBA
02/2002

Therapy/Procedure

5Therapeutics
11/2019 - 03/2002
2Transplantation
01/2003 - 03/2002
1Immunomodulation
03/2019
1Combination Drug Therapy (Combination Chemotherapy)
06/2004
1Anticoagulation Reversal
01/2004